Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golimumab + Methotrexate vs Methotrexate in PsA
NCT01871649Phase 3Completed
- Sponsor
- University of Amsterdam
- Start
- Aug 2013
- Primary completion
- Nov 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of golimumab in psoriatic arthritis (PsA), sponsored by University of Amsterdam. Started Aug 2013; status: completed.
02
Drugs
golimumab
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT01871649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01871649.